Description of maternal and neonatal adverse events in pregnant people immunised with COVID-19 vaccines during pregnancy in the CLAP NETWORK of sentinel sites: nested case–control analysis of the immunization-associated risk – a study protocol

Macías Saint-Gerons, Diego - Castro, José Luis - Colomar, Mercedes - Rojas, Edgard - Sosa, Claudio - Ropero, Alba María - Jacob Serruya, Suzanne - Pastor, Desiré - Chiu, Mónica - Velandia-Gonzalez, Martha - Abalos, Edgardo - Durán, Pablo - Gomez Ponce de León, Rodolfo - Tomasso, Giselle - Mainero, Luis - Rubino, Marcelo - De Mucio, Bremen

Resumen:

Introduction: COVID-19 is associated with higher morbimortality in pregnant people compared with non-pregnant people. At present, the benefits of maternal immunisation are considered to outweigh the risks, and therefore, vaccination is recommended during pregnancy. However, additional information is needed on the safety of the vaccines in this population. Methods and analysis: This a retrospective cohort nested case-control study in pregnant people who attended maternity hospitals from eight Latin American and Caribbean countries. A perinatal electronic clinical history database with neonatal and obstetric information will be used. The proportion of pregnant people immunised with COVID-19 vaccines of the following maternal and neonatal events will be described: preterm infant, small for gestational age, low birth weight, stillbirth, neonatal death, congenital malformations, maternal near miss and maternal death. Moreover, the risk of prematurity, small for gestational age and low birth weight associated with exposure to COVID-19 vaccines will be estimated. Each case will be matched with two groups of three randomly selected controls. Controls will be matched by hospital and mother's age (±3 years) with an additional matching by delivery date and conception time in the first and second control groups, respectively. The estimated required sample size for the main analysis (exposure to any vaccine) concerning 'non-use' is at least 1009 cases (3027 controls) to detect an increased probability of vaccine-associated event risk of 30% and at least 650 cases (1950 controls) to detect 30% protection. Sensitivity and secondary analyses considering country, type of vaccine, exposure windows and completeness of immunisation will be reported. Ethics: The study protocol was reviewed by the Ethical Review Committee on Research of the Pan American Health Organization. Patient informed consent was waived due to the retrospective design and the utilisation of anonymised data (Ref. No: PAHOERC.0546.01). Results will be disseminated in open access journals.

Detalles Bibliográficos
2024
COVID-19
Maternal medicine
Perinatology
VACUNAS CONTRA LA COVID-19
PERINATOLOGÍA
EFECTOS ADVERSOS A LARGO PLAZO
EPIDEMIOLOGÍA
PREVENCIÓN DE ENFERMEDADES
ESTUDIOS DE CASOS Y CONTROLES
MUJERES
EMBARAZO
ENSAYOS CLÍNICOS COMO ASUNTO
RETARDO DEL CRECIMIENTO FETAL
INMUNIZACIÓN
VACUNACIÓN
RECIÉN NACIDO
RECIÉN NACIDO PREMATURO
ESTUDIOS RETROSPECTIVOS
MORTINATO
VACUNAS
Inglés
Universidad de la República
COLIBRI
https://hdl.handle.net/20.500.12008/56078
Acceso abierto
Licencia Creative Commons Atribución (CC - By 4.0)
_version_ 1875692832885309440
author Macías Saint-Gerons, Diego
author2 Castro, José Luis
Colomar, Mercedes
Rojas, Edgard
Sosa, Claudio
Ropero, Alba María
Jacob Serruya, Suzanne
Pastor, Desiré
Chiu, Mónica
Velandia-Gonzalez, Martha
Abalos, Edgardo
Durán, Pablo
Gomez Ponce de León, Rodolfo
Tomasso, Giselle
Mainero, Luis
Rubino, Marcelo
De Mucio, Bremen
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author_facet Macías Saint-Gerons, Diego
Castro, José Luis
Colomar, Mercedes
Rojas, Edgard
Sosa, Claudio
Ropero, Alba María
Jacob Serruya, Suzanne
Pastor, Desiré
Chiu, Mónica
Velandia-Gonzalez, Martha
Abalos, Edgardo
Durán, Pablo
Gomez Ponce de León, Rodolfo
Tomasso, Giselle
Mainero, Luis
Rubino, Marcelo
De Mucio, Bremen
author_role author
bitstream.checksum.fl_str_mv 6429389a7df7277b72b7924fdc7d47a9
a0ebbeafb9d2ec7cbb19d7137ebc392c
c2be1a593bc16fa3ffa80ce838a200ca
e7132498e7c1fe99f7096667baa99b25
c2a37d8e741656a7970bf5ee53588199
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
bitstream.url.fl_str_mv http://localhost:8080/xmlui/bitstream/20.500.12008/56078/5/license.txt
http://localhost:8080/xmlui/bitstream/20.500.12008/56078/2/license_url
http://localhost:8080/xmlui/bitstream/20.500.12008/56078/3/license_text
http://localhost:8080/xmlui/bitstream/20.500.12008/56078/4/license_rdf
http://localhost:8080/xmlui/bitstream/20.500.12008/56078/1/Description+of+maternal+and+neonatal+adverse+events+in+pregnant+people+immunised+with+COVID19+vaccines.pdf
collection COLIBRI
dc.contributor.filiacion.none.fl_str_mv Macías Saint-Gerons Diego, Universidad de Valencia (España). Instituto de Investigación Sanitaria y Centro de Investigación Biomédica en Red de Salud Mental. Departamento de Medicina
Castro José Luis, Fundación para la Innovación, la Formación, la Investigación y el Desarrollo Comunitario (España)
Colomar Mercedes, Universidad de la República (Uruguay). Facultad de Medicina. Departamento de Medicina Preventiva y Social; Unidad de Investigación Clínica y Epidemiológica Montevideo (Uruguay)
Rojas Edgard, Pan American Health Organization (E.E.U.U.). Innovation, Access to Medicines and Health Technologies
Sosa Claudio, Universidad de la República (Uruguay). Facultad de Medicina; Centro Hospitalario Pereira Rossell (Uruguay). Departamento de Obstetricia y Ginecología
Ropero Alba María, Pan American Health Organization (E.E.U.U.)
Jacob Serruya Suzanne, Organización Panamericana de la Salud (Uruguay). Centro Latinoamericano de Perinatología. Salud de la Mujer y Reproductiva
Pastor Desiré, Pan American Health Organization (E.E.U.U.)
Chiu Mónica, Pan American Health Organization (E.E.U.U.)
Velandia-Gonzalez Martha, Pan American Health Organization (E.E.U.U.)
Abalos Edgardo, Centro de Estudios de Estado y Sociedad (Argentina)
Durán Pablo, Organización Panamericana de la Salud (Uruguay). Centro Latinoamericano de Perinatología. Salud de la Mujer y Reproductiva
Gomez Ponce de León Rodolfo, Organización Panamericana de la Salud (Uruguay). Centro Latinoamericano de Perinatología. Salud de la Mujer y Reproductiva
Tomasso Giselle, Unidad de Investigación Clínica y Epidemiológica Montevideo (Uruguay)
Mainero Luis, Organización Panamericana de la Salud (Uruguay). Centro Latinoamericano de Perinatología. Salud de la Mujer y Reproductiva
Rubino Marcelo, Organización Panamericana de la Salud (Uruguay). Centro Latinoamericano de Perinatología. Salud de la Mujer y Reproductiva
De Mucio Bremen, Organización Panamericana de la Salud (Uruguay). Centro Latinoamericano de Perinatología. Salud de la Mujer y Reproductiva
dc.creator.none.fl_str_mv Macías Saint-Gerons, Diego
Castro, José Luis
Colomar, Mercedes
Rojas, Edgard
Sosa, Claudio
Ropero, Alba María
Jacob Serruya, Suzanne
Pastor, Desiré
Chiu, Mónica
Velandia-Gonzalez, Martha
Abalos, Edgardo
Durán, Pablo
Gomez Ponce de León, Rodolfo
Tomasso, Giselle
Mainero, Luis
Rubino, Marcelo
De Mucio, Bremen
dc.date.accessioned.none.fl_str_mv 2026-07-15T15:48:03Z
dc.date.available.none.fl_str_mv 2026-07-15T15:48:03Z
dc.date.issued.none.fl_str_mv 2024
dc.description.abstract.none.fl_txt_mv Introduction: COVID-19 is associated with higher morbimortality in pregnant people compared with non-pregnant people. At present, the benefits of maternal immunisation are considered to outweigh the risks, and therefore, vaccination is recommended during pregnancy. However, additional information is needed on the safety of the vaccines in this population. Methods and analysis: This a retrospective cohort nested case-control study in pregnant people who attended maternity hospitals from eight Latin American and Caribbean countries. A perinatal electronic clinical history database with neonatal and obstetric information will be used. The proportion of pregnant people immunised with COVID-19 vaccines of the following maternal and neonatal events will be described: preterm infant, small for gestational age, low birth weight, stillbirth, neonatal death, congenital malformations, maternal near miss and maternal death. Moreover, the risk of prematurity, small for gestational age and low birth weight associated with exposure to COVID-19 vaccines will be estimated. Each case will be matched with two groups of three randomly selected controls. Controls will be matched by hospital and mother's age (±3 years) with an additional matching by delivery date and conception time in the first and second control groups, respectively. The estimated required sample size for the main analysis (exposure to any vaccine) concerning 'non-use' is at least 1009 cases (3027 controls) to detect an increased probability of vaccine-associated event risk of 30% and at least 650 cases (1950 controls) to detect 30% protection. Sensitivity and secondary analyses considering country, type of vaccine, exposure windows and completeness of immunisation will be reported. Ethics: The study protocol was reviewed by the Ethical Review Committee on Research of the Pan American Health Organization. Patient informed consent was waived due to the retrospective design and the utilisation of anonymised data (Ref. No: PAHOERC.0546.01). Results will be disseminated in open access journals.
dc.format.extent.es.fl_str_mv 10 p.
dc.format.mimetype.es.fl_str_mv application/pdf
dc.identifier.citation.es.fl_str_mv Macías Saint-Gerons D, Castro J, Colomar M y otros. Description of maternal and neonatal adverse events in pregnant people immunised with COVID-19 vaccines during pregnancy in the CLAP NETWORK of sentinel sites: nested case–control analysis of the immunization-associated risk – a study protocol. BMJ Open [en línea]. 2024;14(1). 10 p.
dc.identifier.doi.none.fl_str_mv 10.1136/bmjopen-2023-073095
dc.identifier.eissn.none.fl_str_mv 2044-6055
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.12008/56078
dc.language.iso.none.fl_str_mv en
eng
dc.publisher.es.fl_str_mv BMJ Publishing Group
dc.relation.none.fl_str_mv BMJ Open. 2024;14(1)
dc.rights.license.none.fl_str_mv Licencia Creative Commons Atribución (CC - By 4.0)
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
dc.source.none.fl_str_mv reponame:COLIBRI
instname:Universidad de la República
instacron:Universidad de la República
dc.subject.es.fl_str_mv COVID-19
Maternal medicine
Perinatology
dc.subject.other.es.fl_str_mv VACUNAS CONTRA LA COVID-19
PERINATOLOGÍA
EFECTOS ADVERSOS A LARGO PLAZO
EPIDEMIOLOGÍA
PREVENCIÓN DE ENFERMEDADES
ESTUDIOS DE CASOS Y CONTROLES
MUJERES
EMBARAZO
ENSAYOS CLÍNICOS COMO ASUNTO
RETARDO DEL CRECIMIENTO FETAL
INMUNIZACIÓN
VACUNACIÓN
RECIÉN NACIDO
RECIÉN NACIDO PREMATURO
ESTUDIOS RETROSPECTIVOS
MORTINATO
VACUNAS
dc.title.none.fl_str_mv Description of maternal and neonatal adverse events in pregnant people immunised with COVID-19 vaccines during pregnancy in the CLAP NETWORK of sentinel sites: nested case–control analysis of the immunization-associated risk – a study protocol
dc.type.es.fl_str_mv Artículo
dc.type.none.fl_str_mv info:eu-repo/semantics/article
dc.type.version.none.fl_str_mv info:eu-repo/semantics/publishedVersion
description Introduction: COVID-19 is associated with higher morbimortality in pregnant people compared with non-pregnant people. At present, the benefits of maternal immunisation are considered to outweigh the risks, and therefore, vaccination is recommended during pregnancy. However, additional information is needed on the safety of the vaccines in this population. Methods and analysis: This a retrospective cohort nested case-control study in pregnant people who attended maternity hospitals from eight Latin American and Caribbean countries. A perinatal electronic clinical history database with neonatal and obstetric information will be used. The proportion of pregnant people immunised with COVID-19 vaccines of the following maternal and neonatal events will be described: preterm infant, small for gestational age, low birth weight, stillbirth, neonatal death, congenital malformations, maternal near miss and maternal death. Moreover, the risk of prematurity, small for gestational age and low birth weight associated with exposure to COVID-19 vaccines will be estimated. Each case will be matched with two groups of three randomly selected controls. Controls will be matched by hospital and mother's age (±3 years) with an additional matching by delivery date and conception time in the first and second control groups, respectively. The estimated required sample size for the main analysis (exposure to any vaccine) concerning 'non-use' is at least 1009 cases (3027 controls) to detect an increased probability of vaccine-associated event risk of 30% and at least 650 cases (1950 controls) to detect 30% protection. Sensitivity and secondary analyses considering country, type of vaccine, exposure windows and completeness of immunisation will be reported. Ethics: The study protocol was reviewed by the Ethical Review Committee on Research of the Pan American Health Organization. Patient informed consent was waived due to the retrospective design and the utilisation of anonymised data (Ref. No: PAHOERC.0546.01). Results will be disseminated in open access journals.
eu_rights_str_mv openAccess
format article
id COLIBRI_add7d664270d51a7d59ca7f029a82ee2
identifier_str_mv Macías Saint-Gerons D, Castro J, Colomar M y otros. Description of maternal and neonatal adverse events in pregnant people immunised with COVID-19 vaccines during pregnancy in the CLAP NETWORK of sentinel sites: nested case–control analysis of the immunization-associated risk – a study protocol. BMJ Open [en línea]. 2024;14(1). 10 p.
10.1136/bmjopen-2023-073095
2044-6055
instacron_str Universidad de la República
institution Universidad de la República
instname_str Universidad de la República
language eng
language_invalid_str_mv en
network_acronym_str COLIBRI
network_name_str COLIBRI
oai_identifier_str oai:colibri.udelar.edu.uy:20.500.12008/56078
publishDate 2024
reponame_str COLIBRI
repository.mail.fl_str_mv karina.camps@seciu.edu.uy
repository.name.fl_str_mv COLIBRI - Universidad de la República
repository_id_str 4771
rights_invalid_str_mv Licencia Creative Commons Atribución (CC - By 4.0)
spelling Macías Saint-Gerons Diego, Universidad de Valencia (España). Instituto de Investigación Sanitaria y Centro de Investigación Biomédica en Red de Salud Mental. Departamento de MedicinaCastro José Luis, Fundación para la Innovación, la Formación, la Investigación y el Desarrollo Comunitario (España)Colomar Mercedes, Universidad de la República (Uruguay). Facultad de Medicina. Departamento de Medicina Preventiva y Social; Unidad de Investigación Clínica y Epidemiológica Montevideo (Uruguay)Rojas Edgard, Pan American Health Organization (E.E.U.U.). Innovation, Access to Medicines and Health TechnologiesSosa Claudio, Universidad de la República (Uruguay). Facultad de Medicina; Centro Hospitalario Pereira Rossell (Uruguay). Departamento de Obstetricia y GinecologíaRopero Alba María, Pan American Health Organization (E.E.U.U.)Jacob Serruya Suzanne, Organización Panamericana de la Salud (Uruguay). Centro Latinoamericano de Perinatología. Salud de la Mujer y ReproductivaPastor Desiré, Pan American Health Organization (E.E.U.U.)Chiu Mónica, Pan American Health Organization (E.E.U.U.)Velandia-Gonzalez Martha, Pan American Health Organization (E.E.U.U.)Abalos Edgardo, Centro de Estudios de Estado y Sociedad (Argentina)Durán Pablo, Organización Panamericana de la Salud (Uruguay). Centro Latinoamericano de Perinatología. Salud de la Mujer y ReproductivaGomez Ponce de León Rodolfo, Organización Panamericana de la Salud (Uruguay). Centro Latinoamericano de Perinatología. Salud de la Mujer y ReproductivaTomasso Giselle, Unidad de Investigación Clínica y Epidemiológica Montevideo (Uruguay)Mainero Luis, Organización Panamericana de la Salud (Uruguay). Centro Latinoamericano de Perinatología. Salud de la Mujer y ReproductivaRubino Marcelo, Organización Panamericana de la Salud (Uruguay). Centro Latinoamericano de Perinatología. Salud de la Mujer y ReproductivaDe Mucio Bremen, Organización Panamericana de la Salud (Uruguay). Centro Latinoamericano de Perinatología. Salud de la Mujer y Reproductiva2026-07-15T15:48:03Z2026-07-15T15:48:03Z2024Macías Saint-Gerons D, Castro J, Colomar M y otros. Description of maternal and neonatal adverse events in pregnant people immunised with COVID-19 vaccines during pregnancy in the CLAP NETWORK of sentinel sites: nested case–control analysis of the immunization-associated risk – a study protocol. BMJ Open [en línea]. 2024;14(1). 10 p.https://hdl.handle.net/20.500.12008/5607810.1136/bmjopen-2023-0730952044-6055Introduction: COVID-19 is associated with higher morbimortality in pregnant people compared with non-pregnant people. At present, the benefits of maternal immunisation are considered to outweigh the risks, and therefore, vaccination is recommended during pregnancy. However, additional information is needed on the safety of the vaccines in this population. Methods and analysis: This a retrospective cohort nested case-control study in pregnant people who attended maternity hospitals from eight Latin American and Caribbean countries. A perinatal electronic clinical history database with neonatal and obstetric information will be used. The proportion of pregnant people immunised with COVID-19 vaccines of the following maternal and neonatal events will be described: preterm infant, small for gestational age, low birth weight, stillbirth, neonatal death, congenital malformations, maternal near miss and maternal death. Moreover, the risk of prematurity, small for gestational age and low birth weight associated with exposure to COVID-19 vaccines will be estimated. Each case will be matched with two groups of three randomly selected controls. Controls will be matched by hospital and mother's age (±3 years) with an additional matching by delivery date and conception time in the first and second control groups, respectively. The estimated required sample size for the main analysis (exposure to any vaccine) concerning 'non-use' is at least 1009 cases (3027 controls) to detect an increased probability of vaccine-associated event risk of 30% and at least 650 cases (1950 controls) to detect 30% protection. Sensitivity and secondary analyses considering country, type of vaccine, exposure windows and completeness of immunisation will be reported. Ethics: The study protocol was reviewed by the Ethical Review Committee on Research of the Pan American Health Organization. Patient informed consent was waived due to the retrospective design and the utilisation of anonymised data (Ref. No: PAHOERC.0546.01). Results will be disseminated in open access journals.Submitted by Almiñana María Cecilia (marialminana@gmail.com) on 2026-07-14T15:59:36Z No. of bitstreams: 2 license_rdf: 25630 bytes, checksum: e7132498e7c1fe99f7096667baa99b25 (MD5) Description of maternal and neonatal adverse events in pregnant people immunised with COVID19 vaccines.pdf: 4619396 bytes, checksum: c2a37d8e741656a7970bf5ee53588199 (MD5)Approved for entry into archive by Almiñana María Cecilia (marialminana@gmail.com) on 2026-07-14T16:41:41Z (GMT) No. of bitstreams: 2 license_rdf: 25630 bytes, checksum: e7132498e7c1fe99f7096667baa99b25 (MD5) Description of maternal and neonatal adverse events in pregnant people immunised with COVID19 vaccines.pdf: 4619396 bytes, checksum: c2a37d8e741656a7970bf5ee53588199 (MD5)Made available in DSpace by Luna Fabiana (fabiana.luna@seciu.edu.uy) on 2026-07-15T15:48:03Z (GMT). No. of bitstreams: 2 license_rdf: 25630 bytes, checksum: e7132498e7c1fe99f7096667baa99b25 (MD5) Description of maternal and neonatal adverse events in pregnant people immunised with COVID19 vaccines.pdf: 4619396 bytes, checksum: c2a37d8e741656a7970bf5ee53588199 (MD5) Previous issue date: 202410 p.application/pdfenengBMJ Publishing GroupBMJ Open. 2024;14(1)Las obras depositadas en el Repositorio se rigen por la Ordenanza de los Derechos de la Propiedad Intelectual de la Universidad de la República.(Res. Nº 91 de C.D.C. de 8/III/1994 – D.O. 7/IV/1994) y por la Ordenanza del Repositorio Abierto de la Universidad de la República (Res. Nº 16 de C.D.C. de 07/10/2014)info:eu-repo/semantics/openAccessLicencia Creative Commons Atribución (CC - By 4.0)COVID-19Maternal medicinePerinatologyVACUNAS CONTRA LA COVID-19PERINATOLOGÍAEFECTOS ADVERSOS A LARGO PLAZOEPIDEMIOLOGÍAPREVENCIÓN DE ENFERMEDADESESTUDIOS DE CASOS Y CONTROLESMUJERESEMBARAZOENSAYOS CLÍNICOS COMO ASUNTORETARDO DEL CRECIMIENTO FETALINMUNIZACIÓNVACUNACIÓNRECIÉN NACIDORECIÉN NACIDO PREMATUROESTUDIOS RETROSPECTIVOSMORTINATOVACUNASDescription of maternal and neonatal adverse events in pregnant people immunised with COVID-19 vaccines during pregnancy in the CLAP NETWORK of sentinel sites: nested case–control analysis of the immunization-associated risk – a study protocolArtículoinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionreponame:COLIBRIinstname:Universidad de la Repúblicainstacron:Universidad de la RepúblicaMacías Saint-Gerons, DiegoCastro, José LuisColomar, MercedesRojas, EdgardSosa, ClaudioRopero, Alba MaríaJacob Serruya, SuzannePastor, DesiréChiu, MónicaVelandia-Gonzalez, MarthaAbalos, EdgardoDurán, PabloGomez Ponce de León, RodolfoTomasso, GiselleMainero, LuisRubino, MarceloDe Mucio, BremenLICENSElicense.txtlicense.txttext/plain; charset=utf-84267http://localhost:8080/xmlui/bitstream/20.500.12008/56078/5/license.txt6429389a7df7277b72b7924fdc7d47a9MD55CC-LICENSElicense_urllicense_urltext/plain; charset=utf-844http://localhost:8080/xmlui/bitstream/20.500.12008/56078/2/license_urla0ebbeafb9d2ec7cbb19d7137ebc392cMD52license_textlicense_texttext/html; charset=utf-831351http://localhost:8080/xmlui/bitstream/20.500.12008/56078/3/license_textc2be1a593bc16fa3ffa80ce838a200caMD53license_rdflicense_rdfapplication/rdf+xml; charset=utf-825630http://localhost:8080/xmlui/bitstream/20.500.12008/56078/4/license_rdfe7132498e7c1fe99f7096667baa99b25MD54ORIGINALDescription of maternal and neonatal adverse events in pregnant people immunised with COVID19 vaccines.pdfDescription of maternal and neonatal adverse events in pregnant people immunised with COVID19 vaccines.pdfapplication/pdf4619396http://localhost:8080/xmlui/bitstream/20.500.12008/56078/1/Description+of+maternal+and+neonatal+adverse+events+in+pregnant+people+immunised+with+COVID19+vaccines.pdfc2a37d8e741656a7970bf5ee53588199MD5120.500.12008/560782026-07-15 12:48:03.021oai:colibri.udelar.edu.uy:20.500.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Institucionalhttps://www.colibri.udelar.edu.uyUniversidadhttps://udelar.edu.uy/https://www.colibri.udelar.edu.uy/oai/requestkarina.camps@seciu.edu.uyUruguayopendoar:47712026-07-15T15:48:03COLIBRI - Universidad de la Repúblicafalse
spellingShingle Description of maternal and neonatal adverse events in pregnant people immunised with COVID-19 vaccines during pregnancy in the CLAP NETWORK of sentinel sites: nested case–control analysis of the immunization-associated risk – a study protocol
Macías Saint-Gerons, Diego
COVID-19
Maternal medicine
Perinatology
VACUNAS CONTRA LA COVID-19
PERINATOLOGÍA
EFECTOS ADVERSOS A LARGO PLAZO
EPIDEMIOLOGÍA
PREVENCIÓN DE ENFERMEDADES
ESTUDIOS DE CASOS Y CONTROLES
MUJERES
EMBARAZO
ENSAYOS CLÍNICOS COMO ASUNTO
RETARDO DEL CRECIMIENTO FETAL
INMUNIZACIÓN
VACUNACIÓN
RECIÉN NACIDO
RECIÉN NACIDO PREMATURO
ESTUDIOS RETROSPECTIVOS
MORTINATO
VACUNAS
status_str publishedVersion
title Description of maternal and neonatal adverse events in pregnant people immunised with COVID-19 vaccines during pregnancy in the CLAP NETWORK of sentinel sites: nested case–control analysis of the immunization-associated risk – a study protocol
title_full Description of maternal and neonatal adverse events in pregnant people immunised with COVID-19 vaccines during pregnancy in the CLAP NETWORK of sentinel sites: nested case–control analysis of the immunization-associated risk – a study protocol
title_fullStr Description of maternal and neonatal adverse events in pregnant people immunised with COVID-19 vaccines during pregnancy in the CLAP NETWORK of sentinel sites: nested case–control analysis of the immunization-associated risk – a study protocol
title_full_unstemmed Description of maternal and neonatal adverse events in pregnant people immunised with COVID-19 vaccines during pregnancy in the CLAP NETWORK of sentinel sites: nested case–control analysis of the immunization-associated risk – a study protocol
title_short Description of maternal and neonatal adverse events in pregnant people immunised with COVID-19 vaccines during pregnancy in the CLAP NETWORK of sentinel sites: nested case–control analysis of the immunization-associated risk – a study protocol
title_sort Description of maternal and neonatal adverse events in pregnant people immunised with COVID-19 vaccines during pregnancy in the CLAP NETWORK of sentinel sites: nested case–control analysis of the immunization-associated risk – a study protocol
topic COVID-19
Maternal medicine
Perinatology
VACUNAS CONTRA LA COVID-19
PERINATOLOGÍA
EFECTOS ADVERSOS A LARGO PLAZO
EPIDEMIOLOGÍA
PREVENCIÓN DE ENFERMEDADES
ESTUDIOS DE CASOS Y CONTROLES
MUJERES
EMBARAZO
ENSAYOS CLÍNICOS COMO ASUNTO
RETARDO DEL CRECIMIENTO FETAL
INMUNIZACIÓN
VACUNACIÓN
RECIÉN NACIDO
RECIÉN NACIDO PREMATURO
ESTUDIOS RETROSPECTIVOS
MORTINATO
VACUNAS
url https://hdl.handle.net/20.500.12008/56078